Altavista Wealth Management Has Boosted Home Depot (HD) Holding By $2.26 Million; Profile of 9 Analysts Covering Vectura Group plc (LON:VEC)

April 21, 2018 - By Adrian Erickson

Vectura Group plc (LON:VEC) Logo

Altavista Wealth Management Inc increased Home Depot Inc (HD) stake by 108.74% reported in 2017Q4 SEC filing. Altavista Wealth Management Inc acquired 11,962 shares as Home Depot Inc (HD)’s stock declined 7.15%. The Altavista Wealth Management Inc holds 22,963 shares with $4.35M value, up from 11,001 last quarter. Home Depot Inc now has $204.04 billion valuation. The stock decreased 0.04% or $0.07 during the last trading session, reaching $177.01. About 5.01M shares traded. The Home Depot, Inc. (NYSE:HD) has risen 18.94% since April 21, 2017 and is uptrending. It has outperformed by 7.39% the S&P500.

Among 12 analysts covering Vectura Group PLC (LON:VEC), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Vectura Group PLC had 145 analyst reports since July 28, 2015 according to SRatingsIntel. As per Monday, May 16, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Peel Hunt with “Hold” on Tuesday, October 31. Numis Securities maintained the stock with “Buy” rating in Monday, March 12 report. The stock has “Buy” rating by Citigroup on Thursday, March 2. The rating was maintained by N+1 Singer on Friday, October 13 with “Hold”. The firm earned “Hold” rating on Wednesday, April 4 by Peel Hunt. The stock of Vectura Group plc (LON:VEC) has “Buy” rating given on Friday, May 12 by Numis Securities. The stock has “Buy” rating by Numis Securities on Tuesday, April 25. The stock of Vectura Group plc (LON:VEC) earned “Overweight” rating by JP Morgan on Monday, November 2. The firm has “Buy” rating given on Thursday, September 7 by Numis Securities. See Vectura Group plc (LON:VEC) latest ratings:

20/04/2018 Broker: Shore Capital Rating: Hold New Target: GBX 105.00 Maintain
19/04/2018 Broker: Peel Hunt Rating: Hold New Target: GBX 111.00 Maintain
04/04/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 111.00 Maintain
23/03/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 120.00 New Target: GBX 111.00 Maintain
22/03/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 140.00 New Target: GBX 140.00 Maintain
22/03/2018 Broker: Stifel Nicolaus Rating: Buy New Target: GBX 151.00 Maintain
22/03/2018 Broker: Numis Securities Rating: Buy New Target: GBX 160.00 Maintain
21/03/2018 Broker: N+1 Singer Rating: Buy Old Target: GBX 120.00 New Target: GBX 120.00 Maintain
21/03/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 120.00 New Target: GBX 120.00 Maintain
21/03/2018 Broker: Shore Capital Rating: Hold Maintain

Among 34 analysts covering The Home Depot Inc. (NYSE:HD), 24 have Buy rating, 0 Sell and 10 Hold. Therefore 71% are positive. The Home Depot Inc. had 116 analyst reports since August 19, 2015 according to SRatingsIntel. The rating was upgraded by Nomura to “Buy” on Thursday, June 23. As per Thursday, November 16, the company rating was maintained by Citigroup. Piper Jaffray maintained The Home Depot, Inc. (NYSE:HD) rating on Tuesday, August 15. Piper Jaffray has “Hold” rating and $164.0 target. The firm has “Buy” rating by Deutsche Bank given on Wednesday, August 17. The company was maintained on Friday, October 13 by Robert W. Baird. The firm has “Buy” rating by RBC Capital Markets given on Monday, October 30. The rating was maintained by Robert W. Baird with “Buy” on Thursday, November 30. Morgan Stanley upgraded The Home Depot, Inc. (NYSE:HD) on Thursday, February 23 to “Overweight” rating. Argus Research maintained the shares of HD in report on Wednesday, November 15 with “Buy” rating. Goldman Sachs maintained it with “Neutral” rating and $143 target in Wednesday, April 6 report.

Investors sentiment decreased to 0.93 in Q4 2017. Its down 0.21, from 1.14 in 2017Q3. It is negative, as 51 investors sold HD shares while 662 reduced holdings. 164 funds opened positions while 501 raised stakes. 788.59 million shares or 0.96% less from 796.24 million shares in 2017Q3 were reported. Parametric Port Assoc Ltd Limited Liability Company holds 3.45 million shares or 0.65% of its portfolio. Davidson Inv Advsr has 3,970 shares for 0.08% of their portfolio. Stonehearth Cap Mgmt Limited Liability Corporation holds 0.19% or 1,350 shares in its portfolio. Jennison Limited Liability Company reported 8.23 million shares or 1.54% of all its holdings. St Johns Invest Limited Company holds 0.15% or 1,100 shares. Lincoln Natl has 46,554 shares. Centurylink Invest holds 0.5% in The Home Depot, Inc. (NYSE:HD) or 7,524 shares. Royal Savings Bank Of Canada reported 4.77 million shares or 0.4% of all its holdings. Holderness Invs Commerce holds 2.11% in The Home Depot, Inc. (NYSE:HD) or 22,633 shares. Cincinnati Specialty Underwriters Insur owns 7,000 shares for 1.11% of their portfolio. Mason Street Advsrs Ltd Liability holds 162,658 shares. Guyasuta Inv Inc holds 0.36% in The Home Depot, Inc. (NYSE:HD) or 16,587 shares. Moreover, Sunbelt Secs has 0.71% invested in The Home Depot, Inc. (NYSE:HD). Mark Asset Corporation, New York-based fund reported 1,733 shares. Usa Fincl Portformulas Corp holds 0.61% or 13,511 shares.

Since December 7, 2017, it had 2 insider purchases, and 5 sales for $36.57 million activity. CODINA ARMANDO M bought $1.19M worth of stock or 6,650 shares. Shares for $7.02M were sold by Campbell Ann Marie on Thursday, February 22. Shares for $20.89M were sold by Menear Craig A. On Tuesday, February 27 the insider Decker Edward P. sold $3.31 million. On Thursday, December 7 Roseborough Teresa Wynn sold $1.97 million worth of The Home Depot, Inc. (NYSE:HD) or 10,916 shares. Another trade for 41,396 shares valued at $7.58 million was made by Carey Matt on Friday, December 8. 16,827 shares valued at $3.00M were bought by BRENNEMAN GREGORY D on Wednesday, March 21.

Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases. The company has market cap of 649.23 million GBP. The companyÂ’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease ; AirFlusal Forspiro for the treatment of asthma and COPD; ADVATE for the treatment of haemophilia A; and Adept for the treatment of surgical adhesions. It currently has negative earnings. The Company’s generic products include VR315, VR506, and VR632 for the treatment of asthma; and Phase III clinical stage products include VR475 for the treatment of severe adult asthma, and VR876 for the treatment of lung diseases, as well as NVA237 and QVA149 for the treatment of COPD for which filed NDA to the Food and Drug Administration.

The Home Depot, Inc. (NYSE:HD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: